Medtronic PLC

$ 84.06 -0.17 (-0.2%)
Volume: 2,721,059 Avg Vol (1m): 5,993,642
Market Cap $: 112.86 Bil Enterprise Value $: 128.86 Bil
P/E (TTM): 32.99 P/B: 2.27
Earnings Power Value 32.16
Net Current Asset Value -13.42
Tangible Book -8.2
Projected FCF 66.97
Median P/S Value 79.23
Graham Number 0
Peter Lynch Value 20.72
DCF (FCF Based) 38.29
DCF (Earnings Based) 27.29
YTD (-%)

Financial Strength : 6/10

Current vs industry vs history
Cash-to-Debt 0.37
Equity-to-Asset 0.56
Debt-to-Equity 0.50
Debt-to-EBITDA 2.70
Interest Coverage 6.30
Piotroski F-Score 8
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.91
DISTRESS
GREY
SAFE
Beneish M-Score -2.49
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 8.85%
WACC 4.5%

Profitability & Growth : 9/10

Current vs industry vs history
Operating Margin % 21.50
Net Margin % 16.10
ROE % 9.81
ROA % 5.42
ROC (Joel Greenblatt) % 76.72
3-Year Total Revenue Growth Rate 13.90
3-Year Total EBITDA Growth Rate 20.10
3-Year EPS w/o NRI Growth Rate -2.00

» MDT's 30-Y Financials

Financials (Next Earnings Date: 2019-05-23)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:MDT

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 334510    SIC : 3845
Compare NYSE:ABT NYSE:SYK NAS:ISRG NYSE:BSX NYSE:EW NYSE:ZBH NAS:ALGN LSE:SN. NAS:ABMD NYSE:TFX XSWX:SOON NYSE:VAR SZSE:300003 OCSE:WDH XPAR:DIM ASX:COH LSE:CTEC NZSE:FPH NYSE:GMED OCSE:AMBU B
Traded in other countries MDTC34.Brazil 2M6.Germany MDTN.Mexico 0Y6X.UK
Address Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for about 45% of the company's total sales.

Ratios

Current vs industry vs history
PE Ratio (TTM) 32.99
Forward PE Ratio 15.48
N/A
PE Ratio without NRI 32.99
Price-to-Owner-Earnings 25.35
PB Ratio 2.27
PS Ratio 3.74
Price-to-Free-Cash-Flow 23.51
Price-to-Operating-Cash-Flow 19.21
EV-to-EBIT 19.45
EV-to-EBITDA 13.89
EV-to-Revenue 4.21
PEG Ratio 5.00
Shiller PE Ratio 29.97
Current Ratio 2.36
Quick Ratio 1.92
Days Inventory 150.07
Days Sales Outstanding 69.93
Days Payable 68.68

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 2.37
Dividend Payout Ratio 0.54
3-Year Dividend Growth Rate (Per Share) 14.70
Forward Dividend Yield % 2.37
N/A
Yield-on-Cost (5-Year) % 4.42
3-Year Share Buyback Rate 1.60

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.26
Price-to-DCF (Earnings Based) 3.08
Price-to-Median-PS-Value 1.06
Price-to-Peter-Lynch-Fair-Value 4.06
Earnings Yield (Joel Greenblatt) % 5.16
Forward Rate of Return (Yacktman) % 12.48

More Statistics

Revenue (TTM) (Mil) $ 30,555
EPS (TTM) $ 2.55
Beta 0.69
Volatility % 18.96
52-Week Range $ 78.29 - 100.15
Shares Outstanding (Mil) 1,341.15

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 8
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y